Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|June 24, 2022
Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical ImplicationsAlessandro Del Conte, Elisa De Carlo, Elisa Bertoli, et al.
Cancers|July 26, 2020
"To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive BiomarkersMattia Garutti, Silvia Buriolla, Elisa Bertoli, et al.
International Journal of Molecular Sciences|July 9, 2022
Acquired Resistance to Osimertinib in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?Elisa Bertoli, Elisa De Carlo, Alessandro Del Conte, et al.
Cancers|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New StrategiesBrigida Stanzione, Alessandro Del Conte, Elisa Bertoli, et al.
International Journal of Molecular Sciences|July 14, 2023
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical ImplicationsElisa Bertoli, Elisa De Carlo, Debora Basile, et al.
International Journal of Molecular Sciences|July 9, 2022
The Change in Paradigm for NSCLC Patients with EML4-ALK TranslocationAlessandra Bearz, Elisa De Carlo, Alessandro Del Conte, et al.
Anesthesiology|May 24, 2008
Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterizationMaria Amigoni, Giacomo Bellani, Margherita Scanziani, et al.
International Journal of Molecular Sciences|January 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic ApproachesLorenzo Foffano, Elisa Bertoli, Martina Bortolot, et al.
Frontiers in Oncology|April 2, 2026
BRAF class II-III mutations in NSCLC: a single center experienceSara Torresan, Martina Bortolot, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 11, 2025
EML4-ALK: Update on ALK InhibitorsAlessandra Bearz, Elisa Bertoli, Brigida Stanzione, et al.
Pageof 3